BillionToOne (BLLN) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
12 Jun, 2026Opening remarks and agenda
CEO welcomed stockholders and introduced the meeting, confirming the virtual format and participant rights.
General Counsel called the meeting to order, confirmed notice and proxy materials were distributed, and outlined the agenda.
Board and executive committee updates
Election of two Class I directors, Oguzhan Atay and Akshay Rai, to serve until the 2029 annual meeting was on the agenda.
Corporate governance
Quorum was confirmed, enabling the meeting to transact business.
Inspector of election's oath was filed with the meeting minutes.
Partial view of Summaries dataset, powered by Quartr API
Latest events from BillionToOne
- Tissue-free oncology differentiation and health-system access anchor expansion.BLLN
Stifel 2026 Healthcare Conference 2026 - QCT-backed prenatal profits fund an oncology push, with Clear set for Dec. 15, 2026.BLLN
UBS Global Healthcare Conference - Revenue rose 47.2%, guidance increased, and Northstar Clear is set to launch Dec. 15.BLLN
Q3 2026 - Q2 revenue up 64% with strong margins; health system expansion and innovation drive future growth.BLLN
Wells Fargo 21st Annual Healthcare Conference - Q2 2026 revenue rose 64% to $109.4M, gross margin reached 70%, and net income was $8.1M.BLLN
Q2 2026 - Single molecule diagnostics innovation fuels rapid growth, profitability, and clinical impact.BLLN
46th Annual William Blair Growth Stock Conference - Q1 2026 revenue rose 84% to $108.4M, net income hit $18M, and guidance was raised.BLLN
Q1 2026 - 2026 meeting to elect directors, ratify auditor, and review enhanced executive compensation.BLLN
Proxy filing - 2025 revenue doubled, margins rose, and 2026 guidance increased to $430–$445M.BLLN
Q4 2025